Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

A view from within #LucidLife

As we celebrate our 10 year anniversary, Joanne shares her #LucidLife journey

Lucid Group Communications Limited

- PMLiVE

Global standard for medical writing outlined

International writers' associations aim to strengthen and share best practice

- PMLiVE

McCann Health appoints London and New York heads

Mark Archer and Jamie Avallone both become managing directors

- PMLiVE

Cognite bolsters creative and account teams

David Sartain and Cassandra Johnson join the agency

Deal Watch January 2017

Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

Lundbeck partners with IBM Watson on drug research

The deal will also see it set up a new real world evidence platform

Sanofi reception

Praluent can stay on market for now, says US court

Sanofi and Regeneron win appeal to suspended permanent injunction sought by Amgen

- PMLiVE

FDA approves first steroid for Duchenne muscular dystrophy

Marathon Pharma’s Emflaza is first approved to treat all genetic forms of the condition

- PMLiVE

New philosophies driving transformative healthcare

The key trends and philosophies driving this disruptive and innovative era of healthcare forward

- PMLiVE

Minoryx Therapeutics adds to board of directors

Dr Claude Nicaise joins as an independent board member

Behaviour change that inspires healthy decisions

Push. Nudge. Carrot. Stick. Talk of behaviour change is rife at the moment, and nowhere is this more pertinent than in health

Former Novartis exec joins Genmab

Dr Judith Klimovsky becomes chief development officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links